GENERAL ATLANTIC, L.P. — 13F Holdings & Portfolio

CIK 1017645 · latest 13F-HR filed 2026-05-15

GENERAL ATLANTIC, L.P. manages $2.15B in 13F-reported U.S. long-equity assets across 12 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are DLO (28.17%), CHYM (18.53%), XP (18.23%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 0 new positions, exited 1, added to 3, and trimmed 8.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM

$2.15B

Long-equity book

Holdings

12

Distinct positions

Period

2026-03-31

Filed 2026-05-15

Q/Q Activity

+0 / −1 / ↑3 / ↓8

vs 2025-12-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • EUROPEAN WAX CENTER$28.6M +60.6%
  • XP, INC$20.0M +5.4%
  • GROVE COLLABORATIVE$445.5K +16.4%
Show all 3

Top Trims

  • REVOLUTION MEDICINES-$155.2M -69.3%
  • CHIME-$136.9M -25.6%
  • CENTESSA PHARMACEUTICALS-$99.2M -64.8%
  • DLOCAL-$54.6M -8.3%
  • ALKAMI-$36.3M -13.1%
Show all 8

New Positions

  • No new positions this quarter.
Show all 0

Exited Positions

  • ALIGNMENT HEALTHCARE$260.1M
Show all 1
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 DLOCAL DLO G29018101 $605.1M 28.17% 46,656,695 SH
2 CHIME CHYM 16935C109 $398.2M 18.53% 21,259,683 SH
3 XP, INC XP G98239109 $391.6M 18.23% 20,566,133 SH
4 ALKAMI ALKT 01644J108 $240.3M 11.19% 15,337,495 SH
5 PHARVARIS PHVS N69605108 $226.9M 10.56% 8,031,252 SH
6 EUROPEAN WAX CENTER EWCZ 29882P106 $75.8M 3.53% 13,110,492 SH
7 REVOLUTION MEDICINES RVMD 76155X100 $68.8M 3.20% 707,791 SH
8 NURIX THERAPEUTICS NRIX 67080M103 $63.6M 2.96% 4,101,865 SH
9 CENTESSA PHARMACEUTICALS CNTA 152309100 $53.8M 2.50% 1,354,830 SH
10 RISKIFIED RSKD M8216R109 $20.9M 0.97% 5,324,998 SH
11 GROVE COLLABORATIVE GROV 39957D201 $3.2M 0.15% 2,474,859 SH
12 WEBULL BULL G9572D103 $243.9K 0.01% 50,816 SH
Filing History
Period Filed AUM Holdings Accession
2026-03-31 2026-05-15 $2.15B 12 0000950142-26-001406
2025-12-31 2026-02-17 $2.87B 13 0000950142-26-000395
2025-09-30 2025-11-13 $3.33B 16 0000950142-25-002960